Treatment strategy for early gastric cancer - PubMed (original) (raw)
Review
Treatment strategy for early gastric cancer
J Wang et al. Surg Oncol. 2012 Jun.
Abstract
Gastric cancer ranks the second leading cause of cancer-specific mortality worldwide. With a poor prognosis, 5-year survival rate of gastric cancer is less than 20%-25% in the USA, Europe, and China [1]. However, early gastric cancer(EGC) offers an excellent (over 90%) chance of cure based on surgical resection [2]. As the increasing detection of EGC, more treatment options have been developed both curatively and minimally invasively to maintain a good quality of life(QOL). One of the advanced therapeutic techniques is endoscopic dissection. Improvements in surgical treatment include minimizing lymph node dissection, reconstruction methods, laparoscopy-assisted surgery, and sentinel node navigation surgery(SNNS) [3]. With technological advances, even Natural Orifice Transluminal Endoscopy Surgery (NOTES) and robotic surgery are expected to represent the next revolution [4]. However, there still remains much dispute among these treatments, which arouses further clinical trials to verify. Update of the treatments, controversial indications, prognosis and current strategies for EGC are discussed in this review.
Copyright © 2011 Elsevier Ltd. All rights reserved.
Similar articles
- Hybrid natural orifice transluminal endoscopic surgery: endoscopic full-thickness resection of early gastric cancer and laparoscopic regional lymph node dissection--14 human cases.
Cho WY, Kim YJ, Cho JY, Bok GH, Jin SY, Lee TH, Kim HG, Kim JO, Lee JS. Cho WY, et al. Endoscopy. 2011 Feb;43(2):134-9. doi: 10.1055/s-0030-1255955. Epub 2010 Nov 24. Endoscopy. 2011. PMID: 21108175 - Current status and future perspectives in gastric cancer management.
Roukos DH. Roukos DH. Cancer Treat Rev. 2000 Aug;26(4):243-55. doi: 10.1053/ctrv.2000.0164. Cancer Treat Rev. 2000. PMID: 10913380 Review. - Clinical outcomes of minimally invasive treatment for early gastric cancer in patients beyond the indications of endoscopic submucosal dissection.
Ko WJ, Kim YM, Yoo IK, Cho JY. Ko WJ, et al. Surg Endosc. 2018 Sep;32(9):3798-3805. doi: 10.1007/s00464-018-6105-4. Epub 2018 Feb 20. Surg Endosc. 2018. PMID: 29464402 - Laparoscopic lymph node dissection after endoscopic submucosal dissection: a novel and minimally invasive approach to treating early-stage gastric cancer.
Abe N, Mori T, Takeuchi H, Yoshida T, Ohki A, Ueki H, Yanagida O, Masaki T, Sugiyama M, Atomi Y. Abe N, et al. Am J Surg. 2005 Sep;190(3):496-503. doi: 10.1016/j.amjsurg.2005.05.042. Am J Surg. 2005. PMID: 16105543 Clinical Trial. - Surgical treatment of early gastric cancer.
Nomura S, Kaminishi M. Nomura S, et al. Dig Surg. 2007;24(2):96-100. doi: 10.1159/000101895. Epub 2007 Apr 25. Dig Surg. 2007. PMID: 17460412 Review.
Cited by
- Plasma microRNAs, miR-223, miR-21 and miR-218, as novel potential biomarkers for gastric cancer detection.
Li BS, Zhao YL, Guo G, Li W, Zhu ED, Luo X, Mao XH, Zou QM, Yu PW, Zuo QF, Li N, Tang B, Liu KY, Xiao B. Li BS, et al. PLoS One. 2012;7(7):e41629. doi: 10.1371/journal.pone.0041629. Epub 2012 Jul 30. PLoS One. 2012. PMID: 22860003 Free PMC article. - Extracellular vesicle biomarkers in circulation for the diagnosis of gastric cancer: A systematic review and meta‑analysis.
Xue J, Qin S, Ren N, Guo B, Shi X, Jia E. Xue J, et al. Oncol Lett. 2023 Aug 11;26(4):423. doi: 10.3892/ol.2023.14009. eCollection 2023 Oct. Oncol Lett. 2023. PMID: 37664665 Free PMC article. - Up-Regulation of MiR-1915 Inhibits Proliferation, Invasion, and Migration of _Helicobacter pylori_-Infected Gastric Cancer Cells via Targeting RAGE.
Xu XC, Zhang WB, Li CX, Gao H, Pei Q, Cao BW, He TH. Xu XC, et al. Yonsei Med J. 2019 Jan;60(1):38-47. doi: 10.3349/ymj.2019.60.1.38. Yonsei Med J. 2019. PMID: 30554489 Free PMC article. - C-terminal of E1A binding protein 1 enhances the migration of gastric epithelial cells and has a clinicopathologic significance in human gastric carcinoma.
Wang C, Wang M, Xing B, Chi Z, Wang H, Lie C, Dong H. Wang C, et al. Onco Targets Ther. 2019 Jul 2;12:5189-5200. doi: 10.2147/OTT.S203479. eCollection 2019. Onco Targets Ther. 2019. PMID: 31308691 Free PMC article. Retracted. - Recent developments and innovations in gastric cancer.
Mihmanli M, Ilhan E, Idiz UO, Alemdar A, Demir U. Mihmanli M, et al. World J Gastroenterol. 2016 May 7;22(17):4307-20. doi: 10.3748/wjg.v22.i17.4307. World J Gastroenterol. 2016. PMID: 27158199 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials